Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.69 HKD | +0.21% | +1.96% | +4.45% |
Strengths
- The company returns high margins, thereby supporting business profitability.
- Its low valuation, with P/E ratio at 4.63 and 3.9 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Corporate Financial Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.45% | 1.13B | - | ||
+59.08% | 24.77B | - | - | |
+57.87% | 7.09B | D | ||
+5.36% | 5.58B | C | ||
+0.98% | 4.8B | C+ | ||
+36.96% | 4.35B | - | - | |
+46.76% | 3.29B | - | C+ | |
+10.98% | 2.59B | - | ||
+15.50% | 1.73B | - | C- | |
-12.57% | 1.08B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2666 Stock
- Ratings Genertec Universal Medical Group Company Limited